News

Patent license agreement with KRICT

관리자 │ 2023-10-13

HIT

230

Aevisbio and KRICT signed the patent licensing agreement in connection with low-molecular compounds having celeblon-binding activity and their applications. 
목록

이전글 Chemical Research Center founded at Institut Pasteur Korea, Pan-gyo, Korea
다음글 The 6th Target Protein Dissolution Summit